APPLICATION OF MODERN TECHNOLOGIES ENSURING QUALITY AND SAFETY OF HAEMOCOMPONENT THERAPY IN A MULTIDISCIPLINARY HOSPITAL OF EMERCOM OF RUSSIA
https://doi.org/10.25016/2541-7487-2013-0-4-28-34
Abstract
Since opening of Transfusiology Department in theA.M.NikiforovRussianCenterof Emergency and Radiation Medicine, EMERCOM of Russia, harvesting of blood components has been performed using leukoreduction, plasma quarantine and inactivation of viruses in platelets. During 3 quarters of 2012, 411 doses of red cell-containing media were harvested as compared to 809 doses over the same period in 2013; besides, erythrocyte mass harvesting was discontinued completely in favor of the following higher-quality components: red cells depleted of leukocytes and platelets, erythrocyte suspension without leukocyte and platelet layers in SAGM additive solution and cryopreserved erythrocytes. To provide hemostasis in patients with bleedings, harvesting of fresh frozen plasma (FFP) (770 doses) and platelets (40 doses) was increased in 2013 compared to 2012 (401 and 10 doses, respectively). In 2013, apheresis was more widely used for obtaining platelets and FFP (417 and 99 doses, respectively) compared to 2012 (217 and 22 doses). In order to increase the percentage of FFP to be released for clinical use after quarantining, a permanent contingent of plasma donors is advisable.
About the Authors
A. A. GanapievRussian Federation
Ganapiev Abdulbasyir Abdurahmanovich - DM, Head of Trasfusiology Department
O. A. Bud'ko
Russian Federation
Bud'ko Olga Aleksandrovna - Head of the blood and bone marrow procurement Group, Trasfusiology Department
S. N. Kononenko
Russian Federation
Kononenko Svetlana Nikolaevna - Ph, Head of the Laboratory of blood cells, tissue and bone marrow cryoconservation with cryobank of Trasfusiology Department
References
1. Baratashvili G.G. Vliyanie dvukratnogo diskretnogo eritrotsitafereza na organizm donorov [Influence of a double discrete erythrocytopheresis on the body of donors]. Sankt-Peterburg. 2004. 23 p. (In Russ.)
2. Zhiburt E.B., Shestakov E.A. Pravila i audit perelivaniya krovi [Terms and audit of blood transfusion]. Moskva. 2010. 347 p. (In Russ.)
3. Ob utverzhdenii tselevykh pokazatelei effektivnosti deyatel'nosti federal'nykh gosudarstvennykh uchrezhdenii, nakhodyashchikhsya v vedenii Ministerstva zdravookhraneniya i sotsial'nogo razvitiya Rossiiskoi Federatsii, i kriteriev otsenki effektivnosti raboty ikh rukovoditelei, uslovii premirovaniya rukovoditelei federal'nykh gosudarstvennykh uchrezhdenii, nakhodyashchikhsya v vedenii Ministerstva zdravookhraneniya i sotsial'nogo razvitiya Rossiiskoi Federatsii: prikaz Ministerstva zdravookhraneniya i sotsial'nogo razvitiya Rossii ot 19.03.2010 g. N 169n [On approval of the performance targets of the federal government agencies under the Ministry of Health and Social Development of the Russian Federation, and the criteria for evaluating the performance of their leaders, conditions of awarding heads of federal public institutions under the Ministry of Health and Social Development of the Russian Federation: the order of the Ministry of Health and Social Development of Russia dated 19.03.2010 N 169n.]. (In Russ.)
4. Tekhnicheskii reglament o trebovaniyakh bezopasnosti krovi, ee produktov, krovezameshchayushchikh rastvorov i tekhnicheskikh sredstv, ispol'zuemykh v transfuzionnoinfuzionnoi terapii : postanovlenie Pravitel'stva RF ot 26.01.2010 N 29 [Technical regulation on safety requirements to blood, its products, solutions and blood substitutes, hardware used in transfusioninfusion therapy: RF Government Decree of 26.01.2010 N 29]. (In Russ.)
5. Chechetkin A.V., Kononenko S.N., Papayan L.P. [et al.]. Vliyanie leikofil'tratsii na gemostaticheskie svoistva donorskoi plazmy [Leukofiltration influence on the hemostatic properties of donated plasma]. Transfuziologiya [Transfusiology]. 2011. Vol. 1, N 1. Pp. 13–19. (In Russ.)
6. Blajchman M.A., Bordin J.O. Mechanisms of transfusion-associated immunosupression. Curr. Opin. Hematol. 2001. Vol. 114, N 4. P. 308–316.
7. Seltsam A., Muller T.N. UVC irradiation for pathogen reduction of platelet concetrates and plasma. Transfus. Med. Hemother. 2011. Vol. 38, N 1. Pp. 43–54.
Review
For citations:
Ganapiev A.A., Bud'ko O.A., Kononenko S.N. APPLICATION OF MODERN TECHNOLOGIES ENSURING QUALITY AND SAFETY OF HAEMOCOMPONENT THERAPY IN A MULTIDISCIPLINARY HOSPITAL OF EMERCOM OF RUSSIA. Medicо-Biological and Socio-Psychological Problems of Safety in Emergency Situations. 2013;(4):28-34. (In Russ.) https://doi.org/10.25016/2541-7487-2013-0-4-28-34